May 28, 2015 by Mark Hollmer
NeuWave Medical – developer of a microwave ablation tumor removal tool – pulled in more than $25.3 million in a Series C round led by Versant Ventures.
Madison, Wis.-based NeuWave said all of its existing backers also joined the over-subscribed round, including H.I.G. BioVentures, Venture Investors and others. Read more
May 22, 2015 by Scott Wooldridge
Financing for medtech startups can still be found, but the market climate is less than ideal, panelists at a LifeScience Alley conference said this week in Minneapolis.
The panel, "Financing Opportunities in Today’s Marketplace," discussed venture capital, IPOs, strategic investors and the important role played by a board of directors play. Read more
May 26, 2015 by Brad Perriello
A trio of medtech companies set terms for their upcoming public offerings today, announcing plans to raise a collective $297 million.
Evolent Health, EndoChoice and Corindus Vascular Robotics all set terms today for a pair of initial public offerings and an uplisting (Corindus is looking to move from the OTC exchange to the New York Stock Exchange). Read more
May 26, 2015 by Fink Densford
Breast tissue expansion device maker AirXpanders said yesterday that it filed for an initial public offering in Australia, looking to raise $36.5 million Australian (about $28 million U.S.).
Palo Alto, Calif.-based AirXpanders said it’s planning to float 73 million shares at A50¢ apiece. Read more
May 26, 2015 by Mark Hollmer
California startup ClarVista Medical said it raised a $14 million Series B round slated for development of its adjustable post-cataract surgery intraocular lens replacement. Cycad Group and Windham Venture Partners co-led the round, along with existing investor New Enterprise Associates, ClarVista said.
CEO Paul McLean said the money will help propel the “next phase” of development for ClarVista’s Harmoni modular intraocular lens system. Harmoni consists of 2 parts, a positioning device and an optical lens that can be cheaply and safely upgraded or adjusted over time based on a patient’s evolving vision. Read more